Back to Search
JAMES TUMLIN, M.D.
M.D.
Nephrology Physician
NPI: 1467418053IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
43905(TN)029960(GA)
CMS Specialties
PrimaryNEPHROLOGY
Education
UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Class of 1986
Clinical Trials (3)
3
Linked Trials
1
Recruiting
0
With Results
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
NCT07225387RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
NCT05535920COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
NCT01028287COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
PMID 24159603·J Diabetes Res·2013
2-rct
T-cell receptor-stimulated calcineurin activity is inhibited in isolated T cells from transplant patients.
PMID 19420299·J Pharmacol Exp Ther·2009
4-observational
A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
PMID 17699197·Clin J Am Soc Nephrol·2006
3-trial
Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
PMID 15983954·Am J Kidney Dis·2005
3-trial
Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
PMID 15156530·Semin Nephrol·2004
8-other
Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
PMID 12808169·Nephrol Dial Transplant·2003
3-trial
Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
PMID 12040355·Am Heart J·2002
3-trial
Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.
PMID 10905644·Acad Emerg Med·2000
3-trial
Lupus nephritis: histology, diagnosis, and treatment.
PMID 18937630·Bull NYU Hosp Jt Dis·2008
6-review
Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.
PMID 18668592·Arthritis Rheum·2008
3-trial
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.
PMID 18512819·Arthritis Rheum·2008
4-observational
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response.
PMID 18512814·Arthritis Rheum·2008
4-observational
Efficacy and safety of renal tubule cell therapy for acute renal failure.
PMID 18272842·J Am Soc Nephrol·2008
3-trial
Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.
PMID 18249327·J Cardiothorac Vasc Anesth·2008
1-meta
Contrast-induced nephropathy: is the picture any clearer?
PMID 18077780·Clin J Am Soc Nephrol·2008
6-review
Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.
PMID 17185146·Am J Kidney Dis·2007
1-meta
Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options.
PMID 17702711·Clin J Am Soc Nephrol·2007
6-review
Loss of the alpha-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-beta.
PMID 17318077·Transplantation·2007
7-preclinical
Strategies to reduce the risk of contrast-induced nephropathy.
PMID 16949381·Am J Cardiol·2006
6-review
Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary.
PMID 17224862·Rev Cardiovasc Med·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 251 N LYERLY ST, SUITE 100
CHATTANOOGA, TN 37404 - Phone
- (423) 826-8000
Quick Facts
- NPI
- 1467418053
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 40
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile